Dr. Jamieson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-0000Fax+1 919-966-7772
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1995 - 1999
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1992 - 1995
Wroclaw Medical UniversityClass of 1987
Certifications & Licensure
NC State Medical License 2012 - 2025
IA State Medical License 2008 - 2014
FL State Medical License 1999 - 2013
IL State Medical License 1992 - 1999- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor Start of enrollment: 2006 Sep 01
- Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens Start of enrollment: 2006 Jul 01
- HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide Start of enrollment: 2016 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 89 citationsNational Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant CyclophosphamideBronwen E. Shaw, Antonio Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani
Journal of Clinical Oncology. 2021-04-27 - 81 citationsInterim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet countsMoshe Talpaz, Ronald Paquette, Lawrence B. Afrin, Solomon I. Hamburg, Josef T. Prchal
Journal of Hematology & Oncology. 2013-10-29 - 14 citationsIncreasing Rates of Fluoroquinolone Resistance in Escherichia coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant...Christopher G. Hauck, Pearlie P. Chong, Melissa B. Miller, Katarzyna Jamieson, Jason P. Fine
Pathogens & Immunity. 2016-09-20
Abstracts/Posters
- Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (_6...Katarzyna Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AMLKatarzyna Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
